Abstract No. 200 Correlation between tumor-to-normal ratio in pre-treatment MRI and technetium-99 macroaggregated albumin in patients with hepatocellular carcinoma treated with yttrium-90

A Bode,A Villalobos,B Majdalany,Z Bercu,M Cristescu,M Loya,D Schuster,D Brandon,N Kokabi

doi:10.1016/j.jvir.2022.03.281

Abstract No. 200 Correlation between tumor-to-normal ratio in pre-treatment MRI and technetium-99 macroaggregated albumin in patients with hepatocellular carcinoma treated with yttrium-90

A Bode, A Villalobos + Show 7 more

https://doi.org/10.1016/j.jvir.2022.03.281

Copy DOI

Journal: Journal of Vascular and Interventional Radiology

Publication Date: May 27, 2022

Affiliation: Emory University

#Tumor-to-normal Ratio #Pre-treatment MRI + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

To quantify the relationship between tumor-to-normal ratio (TNR) attained from the pre-treatment multi-phase liver MRI compared with that from planning technetium-99m macroaggregated albumin (MAA) SPECT/CT in patients with hepatocellular carcinoma (HCC) undergoing Yttrium-90 radioembolization (Y-90-RE) treatment planning

Full Text